Site içinde arama yapın

Rutuja Bhosale bir dosya eklendi Others
2025-11-17 10:03:59 -

How Is Ultomiris Capturing Share in the Global Complement Inhibitor Drug Market?
Ultomiris Drug Market Overview 2025–2033: Size, Growth Drivers, Key Segments, and Competitive Landscape The Ultomiris drug market is experiencing one of the fastest growth trajectories in the rare disease and biologics sector. Ultomiris (ravulizumab-cwvz), developed and marketed by AstraZeneca (through its subsidiary Alexion Pharmaceuticals, acquired in 2021), has...

0 Yorumlar 0 hisse senetleri 343 Views 0 önizleme

Please log in to like, share and comment!
Rutuja Bhosale bir dosya eklendi Business Networking
2025-12-03 06:59:10 -

What Are the Biggest Challenges Facing the Ultomiris Drug Market Today?
Ultomiris Drug Market Overview 2025–2033: Growth, Key Drivers, Segments, and Future Outlook The Global Ultomiris Drug Market is on a remarkable growth trajectory. Industry forecasts project the market to expand from USD 5.2 billion in 2025 to USD 14.9 billion by 2033, achieving a strong compound annual growth rate (CAGR) of 14.4% throughout the forecast period. Developed and...

0 Yorumlar 0 hisse senetleri 133 Views 0 önizleme

Please log in to like, share and comment!